ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Galapagos Acquires Service Firm Argenta

by Michael McCoy
February 8, 2010 | APPEARED IN VOLUME 88, ISSUE 6

Galapagos, a Belgian biotech firm, has acquired Argenta Discovery’s Services Division for about $23 million. A provider of medicinal chemistry, computational chemistry, and biological services, Argenta employs 140 people in the U.K. Galapagos says it will combine Argenta with its BioFocus unit to create one of the world’s largest drug discovery service organizations, with 390 employees and annual sales of almost $100 million. Argenta’s respiratory drug discovery arm will continue as a separate company called Pulmagen Therapeutics.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment